Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy 23andMe (ME) shares
Learn how to easily invest in 23andMe shares.
23Andme Holding Co (ME) is a leading diagnostics & research business based in the US. It opened the day at USD$2.23 after a previous close of USD$2.23. During the day the price has varied from a low of USD$2.22 to a high of USD$2.275. The latest price was USD$2.25 (25 minute delay). 23andMe is listed on the NASDAQ and employs 0 staff. All prices are listed in US Dollars.
Global stock trading
US stock trading
How to buy shares in 23andMe
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table. To buy shares in a US-listed company from New Zealand, you'll need to find a trading platform that allows access to US markets.
- Open and fund your share trading account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for 23Andme Holding Co. Find the stock by name or ticker symbol – ME – and research it before deciding if it's a good investment for you.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of ME, depending on your share trading account.
- Purchase now or later. Buy your desired number of shares today with a market order or use a limit order to delay your purchase until ME reaches a desired price.
- Check in on your investment. Congratulations, you own a part of 23Andme Holding Co. Optimise your portfolio by tracking your stock — and even the business — performs with an eye on the long term.
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
23andMe shares at a glance
|52-week range||$2.02 - $6.31|
|50-day moving average||$2.47|
|200-day moving average||$2.85|
|Wall St. target price||$5.69|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.73|
23andMe stock price (NASDAQ:ME)Use our graph to track the performance of ME stocks over time.
23andMe price performance over time
Historical closes compared with the close of $2.25 from 2023-03-24
|1 week (2023-03-21)||-1.32%|
|1 month (2023-02-28)||-10.36%|
|3 months (2022-12-28)||8.70%|
|6 months (2022-09-28)||-30.12%|
|1 year (2022-03-28)||-40.00%|
|2 years (2021-03-26)||-78.16%|
|3 years (2020-03-24)||N/A|
|5 years (2018-03-24)||N/A|
|Revenue TTM||$307.7 million|
|Gross profit TTM||$132.9 million|
|Return on assets TTM||-17.44%|
|Return on equity TTM||-37.04%|
|Market capitalisation||$1 billion|
TTM: trailing 12 months
23andMe share dividends
We're not expecting 23andMe to pay a dividend over the next 12 months.
23andMe share price volatility
Over the last 12 months, 23andMe's shares have ranged in value from as little as $2.02 up to $6.31. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 23andMe's is 1.4179. This would suggest that 23andMe's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No. 3) Limited to leverage genetic insights to validate, develop, and commercialize drugs.
Frequently asked questions
23andMe in the news
23andMe Aims To Raise Awareness of Lipoprotein(a), a Little-Known Genetic Risk Factor for Cardiovascular Disease
23andMe Announces Presentation of Phase 1 Clinical Data for 23ME-00610, an Investigational Antibody Targeting CD200R1, at the American Association for Cancer Research (AACR) Annual Meeting 2023
AI Revolution on the Horizon: 2 High-Potential Growth Stocks to Watch in 2023
More guides on Finder
How to buy Credit Suisse Group (CS) shares
Steps to owning and managing Credit Suisse Group, with 24-hour and historical pricing before you buy.
The rise of fin-fluencers: 44% of gen Z investors get money tips on social media
Social media is the number 1 source of investing advice among young adults in New Zealand, according to new research from Finder.
How to invest in the Porsche IPO from New Zealand
Everything we know about the upcoming Porsche IPO, plus information on how to buy in.
Share trading statistics New Zealand
Find out how Kiwis are investing their money, why they choose to invest and why many are still reluctant with our share trading statistics.
How to buy AMTD Digital (HKD) shares
Steps to owning and managing AMTD Digital Inc., with 24-hour and historical pricing before you buy.
The best stock trading apps in NZ (2023)
An overview of the best investing apps available in NZ, including pros, cons and fees.
How to invest money in New Zealand in 2023
What’s the best way to invest money in New Zealand? Find out about KiwiSaver, index funds, cryptocurrency and more in this guide.
BlackBull Markets share trading review
Your detailed review of share trading with BlackBull Markets, including brokerage fees, safety, pros and cons, and more.
Jarden Direct Share Trading review
Thinking of trading shares with Jarden Direct? Check out our review of Jarden Direct fees, safety, and pros and cons first.